|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-5-19
|
|
pubmed:abstractText |
Immunocytochemistry has been proven able to identify tumor cells in bone marrow aspirate (BMA) of patients with SCLC. However, few data exist about the clinical significance of the procedure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
181-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9553663-Antibodies, Monoclonal,
pubmed-meshheading:9553663-Antigens, Neoplasm,
pubmed-meshheading:9553663-Bone Marrow,
pubmed-meshheading:9553663-Carcinoma, Small Cell,
pubmed-meshheading:9553663-Discriminant Analysis,
pubmed-meshheading:9553663-Female,
pubmed-meshheading:9553663-Humans,
pubmed-meshheading:9553663-Immunoenzyme Techniques,
pubmed-meshheading:9553663-Lung Neoplasms,
pubmed-meshheading:9553663-Male,
pubmed-meshheading:9553663-Prognosis,
pubmed-meshheading:9553663-Prospective Studies,
pubmed-meshheading:9553663-Tumor Markers, Biological
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer.
|
|
pubmed:affiliation |
Cattedra di Oncologia Medica, Università di Verona, Italy.
|
|
pubmed:publicationType |
Journal Article
|
